Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic

Introduction: People living with HIV (PLWH) are mainly African or Asian, the majority female. In contrast, pharmaceutical companies typically conduct phase 3 regulatory randomised controlled trials (RCTs) in high-income countries (HICs), where PLWH are mainly white males. Regulatory authorities can...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Toby Pepperrell, Andrew Hill, Michelle Moorhouse, Polly Clayden, Kaitlyn McCann, Simiso Sokhela, Celicia Serenata, Willem Daniel Francois Venter
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2020-04-01
coleção:	Journal of Virus Eradication
Assuntos:	clinical trials HIV black females antiretrovirals phase 3
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2055664020300194
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!